Showing 19,861 - 19,880 results of 74,299 for search '(( 50 ((((teer decrease) OR (nn decrease))) OR (a decrease)) ) OR ( i e decrease ))', query time: 1.60s Refine Results
  1. 19861

    Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease by Yagahira E. Castro-Sesquen (284439)

    Published 2014
    “…The nanoparticles concentrate <i>T. cruzi</i> antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%–98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%–57.26%). …”
  2. 19862
  3. 19863

    DataSheet_3_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

    Published 2023
    “…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”
  4. 19864

    DataSheet_4_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

    Published 2023
    “…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”
  5. 19865

    DataSheet_2_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

    Published 2023
    “…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”
  6. 19866

    DataSheet_1_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

    Published 2023
    “…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”
  7. 19867
  8. 19868
  9. 19869

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    “…Chloramphenicol treated sample showed a decrease of half max intensity 30 mins after treatment.…”
  10. 19870

    α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism by R.P. de Lima (12728413)

    Published 2022
    “…This was associated with a decrease in AMP-activated protein kinase (AMPK) activity, an increase of mechanistic target of rapamycin complex 1 (mTORC1) signaling, and enhanced sterol regulatory element binding protein 1 (SREBP1) expression, which have roles in lipogenesis, inhibition of lipolysis, and inflammatory response. …”
  11. 19871
  12. 19872
  13. 19873

    Effect of <i>HMO1</i> and/or <i>FPR1</i> deletion on transcription. by Koji Kasahara (16607)

    Published 2020
    “…(B) Venn diagrams of genes whose transcription was decreased or increased by <i>HMO1</i> and/or <i>FPR1</i> deletion. …”
  14. 19874
  15. 19875

    Intermediate metabolites produced by <i>S</i>. <i>aureus</i> are sensed and utilized as carbon sources by <i>P</i>. <i>aeruginosa</i>. by Tiffany M. Zarrella (12902741)

    Published 2022
    “…For panels B and D, data shown represent 3 independent replicates and error bars denote the SD. <b>(E)</b> Growth of <i>P</i>. <i>aeruginosa</i> was monitored at OD<sub>600</sub> after the addition of 1 mM glucose, citric acid, 2,3-butanediol, acetoin, or a mix of citric acid, 2,3-butanediol, and acetoin as the sole carbon sources. …”
  16. 19876

    Newborn cholinesterase double-KO mice present strong skeletal phenotypes. by Janine Spieker (3092895)

    Published 2017
    “…Note, in mutants A-blu staining is stronger in areas where mineralization is decreased, e.g. in distal long bones (b, stippled arrow) and dorsal ribs; A-blu is absent in ventral ribs (b, star) and hind limb joints (b, stippled circle). …”
  17. 19877

    Reduction of Alcian blue staining in <i>fam20b</i> and <i>xylt1</i> mutants is less severe than in <i>uxs1</i> mutants. by B. Frank Eames (208061)

    Published 2011
    “…<p>AE, Alcian blue-stained 6 dpf ceratohyals. Compared to wild types (A), Alcian blue staining appeared lower in <i>fam20b<sup>b1127</sup></i> (B) and <i>xylt1<sup>b1128</sup></i> (C) mutants. …”
  18. 19878

    <i>sgk-1</i> and <i>rict-1</i> mutants have reduced levels of prohibitins. by Roxani Gatsi (636120)

    Published 2014
    “…<p>Western blot analysis showing actin, PHB-1 and PHB-2 protein levels of wild type, <i>sgk-1(ok538), daf-2(e1370), daf-2(e1370); sgk-1(ok538), rict-1(ft7) and sgk-1(ft15)</i> animals treated with <i>control RNAi</i> (<i>−</i>) or <i>phb-1</i> RNAi (+) (upper panel) and graphical representation of the quantification of PHB-1 average pixel intensity under the corresponding conditions normalized to the actin signal levels (lower panel). …”
  19. 19879
  20. 19880